# A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls

> **NCT07217886** · PHASE1 · RECRUITING · sponsor: **Shionogi** · enrollment: 40 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** S-892216-PO

## Key facts

- **NCT ID:** NCT07217886
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-16
- **Primary completion:** 2026-06-05
- **Final completion:** 2026-06-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07217886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07217886, "A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07217886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*